Teva Pharmaceutical Industries Limited (TEVA) Stake Lessened by Stephens Inc. AR

Stephens Inc. AR reduced its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 12.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,432 shares of the company’s stock after selling 4,579 shares during the quarter. Stephens Inc. AR’s holdings in Teva Pharmaceutical Industries Limited were worth $571,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of TEVA. San Francisco Sentry Investment Group CA acquired a new position in shares of Teva Pharmaceutical Industries Limited during the 2nd quarter worth about $106,000. Kistler Tiffany Companies LLC raised its position in shares of Teva Pharmaceutical Industries Limited by 74.7% during the 2nd quarter. Kistler Tiffany Companies LLC now owns 3,673 shares of the company’s stock worth $122,000 after purchasing an additional 1,571 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its position in shares of Teva Pharmaceutical Industries Limited by 2.6% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,711 shares of the company’s stock worth $123,000 after purchasing an additional 94 shares during the last quarter. Penserra Capital Management LLC acquired a new position in shares of Teva Pharmaceutical Industries Limited during the 3rd quarter worth about $129,000. Finally, Cutler Capital Management LLC acquired a new position in shares of Teva Pharmaceutical Industries Limited during the 2nd quarter worth about $133,000. 52.29% of the stock is currently owned by institutional investors and hedge funds.

Teva Pharmaceutical Industries Limited (NYSE TEVA) traded up $0.22 during trading on Friday, hitting $13.71. 13,093,542 shares of the stock traded hands, compared to its average volume of 15,437,631. Teva Pharmaceutical Industries Limited has a twelve month low of $10.85 and a twelve month high of $38.49. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.66 and a current ratio of 0.96. The stock has a market cap of $13,695.68, a PE ratio of 3.11 and a beta of 0.52.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Tuesday, November 28th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Monday, November 27th. This represents a $0.34 annualized dividend and a dividend yield of 2.48%. Teva Pharmaceutical Industries Limited’s dividend payout ratio (DPR) is -15.80%.

Several research analysts recently weighed in on the stock. Mizuho restated a “hold” rating and set a $30.00 price target on shares of Teva Pharmaceutical Industries Limited in a research report on Wednesday, August 2nd. CIBC restated a “market perform” rating on shares of Teva Pharmaceutical Industries Limited in a research report on Thursday, August 3rd. UBS AG downgraded shares of Teva Pharmaceutical Industries Limited from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 3rd. Credit Suisse Group set a $39.00 price target on shares of Teva Pharmaceutical Industries Limited and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, Oppenheimer Holdings, Inc. downgraded shares of Teva Pharmaceutical Industries Limited from an “outperform” rating to a “market perform” rating and set a $41.00 price target for the company. in a research report on Thursday, August 3rd. Seven investment analysts have rated the stock with a sell rating, seventeen have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $21.88.

TRADEMARK VIOLATION NOTICE: “Teva Pharmaceutical Industries Limited (TEVA) Stake Lessened by Stephens Inc. AR” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://sportsperspectives.com/2017/11/24/teva-pharmaceutical-industries-limited-teva-stake-lessened-by-stephens-inc-ar.html.

Teva Pharmaceutical Industries Limited Company Profile

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Institutional Ownership by Quarter for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Receive News & Ratings for Teva Pharmaceutical Industries Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply